Jefferies downgraded Pactiv Evergreen (PTVE) to Hold from Buy with a price target of $18, up from $15. The firm cites the sale to Novolex for the downgrade and views the regulatory risk as manageable.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTVE: